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ABSTRACT 
3-Aminobenzanthrone (3-ABA) is a human metabolite of carcinogenic 3-nitrobenzanthrone 
(3-NBA), which occurs in diesel exhaust and air pollution. Understanding which cytochrome 
P450 (CYP) enzymes are involved in metabolic activation and/or detoxication of this toxicant 
is important in the assessment of an individual’s susceptibility to this substance. The aim of 
this study was to evaluate the efficiency of rat hepatic CYPs to oxidize 3-ABA and to 
examine the metabolites formed during such an oxidation. The metabolites formed by CYPs 
in rat hepatic microsomes were separated by high performance liquid chromatography 
(HPLC). 3-ABA is oxidized by these enzymes to three metabolites, which were separated by 
HPLC as distinguish product peaks. Using co-chromatography with synthetic standards, two 
of them were identified to be oxidative metabolites of 3-ABA, N-hydroxy-3-ABA and 3-
NBA. The structure of another 3-ABA metabolite remains to be characterized. To define the 
role of rat hepatic CYP enzymes in metabolism of 3-ABA, we investigated the modulation of 
its oxidation using different inducers of CYPs for treatment of rats to enrich the liver 
microsomes with individual CYPs. Based on these studies, we attribute most of 3-ABA 
oxidation in rat hepatic microsomes to CYP2B, followed by CYP1A, although a role of other 
hepatic CYPs cannot be ruled out. Inhibition of 3-ABA oxidation by selective inhibitors of 
individual CYPs, supported this finding.  
 
Introduction 
3-Aminobenzanthrone (3-ABA, Fig. 1) is the reductive metabolite of the carcinogenic 
environmental pollutant, nitroketone 3-nitrobenzanthrone (3-nitro-7H-benz[de]anthracen-7-
one, 3-NBA, Fig. 1) (Hansen et al., 2007; Svobodová et al., 2007). In recent years 3-NBA has 
received much attention due to its presence in diesel exhaust and its extremely high mutagenic 
potency in the Ames Salmonella assay (Enya et al., 1997; Seidel et al., 2002; Arlt, 2005). 3-
 3
NBA is carcinogenic in rats, causing lung tumours after intratracheal instillation, and it is also 
a suspected human carcinogen (Seidel et al., 2002; Arlt, 2005; Nagy et al., 2005). The uptake 
of 3-NBA in humans has been demonstrated, because its metabolite 3-ABA has been found in 
urine samples of salt mine workers occupationally exposed to diesel emissions (Seidel et al., 
2002). 3-ABA was also the main metabolite of 3-NBA formed in human fetal bronchial cells 
and rat lung alveolar type II cells (Borlak et al., 2000). In addition, 3-ABA was evaluated to 
be suitable for coloration of microporous polyethylene films, which are widely used for 
practical purposes such as separation of liquid mixtures, in particular, as separation 
membranes in chemical batteries (Grabchev et al., 2002), or an advantageous fluorescent 
phospholipid membrane label in the form of its N-palmitoyl derivative (Sykora et al., 2002). 
This suggests its industrial and/or laboratory utilization. Furthermore, genotoxicity of 3-NBA 
and 3-ABA has been documented by the detection of specific DNA adducts formed in vitro as 
well as in vivo in rodents in various tissues (Arlt et al., 2001; 2002; 2003a; b; c; 2004a; c; 
2005; 2006b; Bieler et al., 1999; 2005; 2007; Stiborová et al., 2006; 2008). The predominant 
DNA adducts formed form 3-NBA and 3-ABA are N-(2’-deoxyguanosin-N2-yl)-3-
aminobenzanthrone (dG-N2-ABA) and N-(2’-deoxyguanosin-8-yl)-3-aminobenzanthrone (dG-
C8-N-ABA) and these are most probably responsible for the induction of GC to TA 
transversion mutations induced by these toxicants (Arlt et al., 2004a; Arlt et al., 2006b; Bieler 
et al., 2007).  
Even though the epidemiological study on the toxicity of 3-ABA has not yet been 
evaluated, formation of DNA adducts by this reductive metabolite of 3-NBA in vitro and in 
vivo in rodents inducing these transversion mutations indicates its potential genotoxicity. 
Understanding which enzymes are involved in the metabolism (activation and/or 
detoxication) of 3-ABA is important in the assessment of susceptibility to this 3-NBA 
metabolite. Recently, we have found that cytochromes P450 (CYP) 1A1 and 1A2 are essential 
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for 3-ABA oxidative activation in human and rat livers, forming the same DNA adducts that 
are formed in vivo by 3-ABA or 3-NBA (Arlt et al., 2004b). CYP1A1 is also efficient 
activator of 3-ABA in microsomes of rat kidneys and lungs, while prostaglandin H synthase 
(cyclooxygenase) plays a minor role in this subcellular fraction (Stiborová et al., 2008). 
Previous results also indicate that besides microsomal CYP enzymes cytosolic peroxidases 
might play a role in the oxidative activation of 3-ABA, mainly in extrahepatic tissues such as 
kidneys and lungs (Arlt et al., 2006a, Stiborová et al., 2006; 2008).  In in-vitro experiments, 
mammalian cyclooxygenase, lactoperoxidase and myeloperoxidase were found to be effective 
in activating 3-ABA (Arlt et al., 2006a) (Fig. 1). 
In contrast to the enzymes activating 3-ABA to species binding to DNA, those 
participating in 3-ABA oxidation to other potential metabolites have not been extensively 
studied so far. Therefore, here we investigated the oxidative metabolism of 3-ABA in vitro, in 
order to characterize the 3-ABA metabolites and to identify CYPs responsible for their 
formation. Hepatic microsomes of untreated (control) rats and those treated with two CYP 
inducers, namely, β-naphthoflavone (β-NF), which induces CYP1A and phenobarbital (PB), 
which induces CYP2B, were used for such a study. The selective inhibitors of individual CYP 
enzymes were also utilized to identify the most important enzymes oxidizing 3-ABA.  
 
Materials and methods 
Synthesis of 3-ABA and N-hydroxy-3-ABA (N-OH-ABA) 
3-ABA and N-OH-ABA were synthesized as described (Arlt et al., 2003a) and their 
authenticity was confirmed by UV spectroscopy, electrospray mass spectra and high field 
proton NMR spectroscopy. 
Animal experiments and preparation of microsomes 
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The study was conducted in accordance with the Regulations for the Care and Use of 
Laboratory Animals (311/1997, Ministry of Agriculture, Czech Republic), which complies 
with Declaration of Helsinki. Microsomes from livers of ten male untreated Wistar rats and  
those of rats pretreated with β-NF (Sigma, UK) and PB were prepared by the procedure 
described previously (Stiborová et al., 2002). Rat liver microsomes contained 0.6 nmol 
CYP/mg protein, respectively. Hepatic microsomes of rats treated with β-NF and PB 
contained 1.3 and 1.5 nmol CYP/mg proteins, respectively.  
Incubations 
Incubation mixtures, in a final volume of 500 µl, consisted of 100 mM potassium phosphate 
buffer (pH 7.4), 10 mM NADPH, 0.5 mg of microsomal protein and 5 - 50 µM 3-ABA 
(dissolved in dimethyl sulfoxide, DMSO). The reaction was initiated by adding 3-ABA. 
Incubations with rat microsomes were carried out at 37 for 5-180 minutes. Control 
incubations were carried out either (1) without the enzymatic system (microsomes) or (2) with 
microsomes and 3-ABA, but without NADPH. Then, 5 µl of 1 mM phenacetine in methanol 
was added as an internal standard and 3-ABA and its metabolites were extracted twice with 
ethyl acetate (2 x 1.5 ml). The extracts were evaporated to dryness; residues were dissolved in 
30 µl of methanol and subjected to reverse-phase (RP)-HPLC to evaluate the amounts of 
residual 3-ABA and its metabolites.  
HPLC  
The HPLC was performed with a reversed phase column (Nucleosil 100-5 C18, Macherey-
Nagel, Duren, Germany, 25 cm x 4.6 mm, 5 µm) proceeded by a C-18 guard column, using 
isocratic elution conditions of 70% methanol in distilled water with a flow rate of 0.6 ml/min. 
The HPLC was carried out with a Dionex HPLC pump P580 with UV/VIS UVD 170S/340S 
spectrophotometer detector set at 254 nm, and peaks were integrated with a 
CHROMELEONTM 6.01 integrator. 
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Inhibition studies  
The following chemicals were used to inhibit 3-ABA oxidation in the presence of rat hepatic 
microsomes: α-naphthoflavone (α-NF), which inhibits CYP1A1 and 1A2, furafylline, which 
inhibits CYP1A2, diamantane, an inhibitor of CYP2B, sulfophenazole, which inhibits CYP2C 
and diethyldithiocarbamate, which inhibits CYP2E1 (Rendic and DiCarlo, 1997). Inhibitors 
were dissolved in 7.5 µl of methanol or water (in the case of diethyldithiocarbamate), to yield 
final concentrations of 0.01 - 0.1 mM in the incubation mixtures. Mixtures were then 
incubated at 37ºC for 5 min with NADPH prior to adding 3-ABA, and then incubated for a 
further 20 min at 37ºC. After the incubation, 3-ABA and its metabolites were extracted and 
analyzed by HPLC as described above. 
 
Results 
3-Aminobenzanthrone is oxidized by rat hepatic CYP enzymes in microsomes up to three 
metabolites (see Fig. 2 for hepatic microsomes of rats treated with β-NF). These metabolites 
were separated by HPLC as distinguish product peaks (Fig. 2A). Using co-chromatography 
with synthetic standards, two of them were identified to be the oxidative metabolites of 3-
ABA (Fig. 2B), N-hydroxy-3-ABA (Fig. 2C) and 3-NBA (Fig. 2D). Structures of another 
metabolite eluted with the retention time (r.t.) of 18 min, M18 (Fig. 2A), remains to be 
characterized.  
In order to evaluate the role of the rat hepatic CYPs in oxidation of 3-ABA, hepatic 
microsomes of rats treated with inducers of several CYPs (β-NF as an inducer of CYP1A1/2 
and PB as an inducer of CYP2B) were used. All these microsomes as well as those of the 
untreated (control) rats were capable of oxidizing 3-ABA. Under the experimental conditions 
used, the most efficient microsomes oxidizing 3-ABA were those isolated from livers of rats 
treated with PB (rich in CYP2B), followed by those isolated from livers of rats treated with β-
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NF (rich in CYP1A) and by control microsomes (Fig. 3). This finding suggests that CYPs of a 
2B subfamily, followed by those of a 1A subfamily might play an important role in 3-ABA 
oxidation. Whereas hepatic microsomes rich in CYP1A (β-NF-microsomes) generated the 
final oxidative metabolite of 3-ABA, 3-NBA, this metabolite was not generated by other 
microsomes tested in this study. The metabolite with unknown structure, M18, was only 
formed from 3-ABA by these enzymatic systems (Fig. 3) 
The role of rat hepatic CYP enzymes in 3-ABA oxidation was further investigated by 
modulation of this reaction by selective inhibitors of individual CYPs. Of the inhibitors used 
in the study, diamantane, an inhibitor of CYP2B, was the most efficient inhibitor of 3-ABA 
oxidation with the IC50 value of 0.9 µM, followed by α-NF, sulfaphenazole and furafylline, 
inhibitors of CYP1A1/2, 2C and 1A2, respectively. The lowest inhibition efficacy was found 
for an inhibitor of CYP2E1, diethyldithiocarbamate. The IC50 values are shown in Table 1. 
These results supported the data found in the experiments with CYP inducers; CYP2B, 
followed by CYP1A, seem to be the most efficient in 3-ABA oxidation, whereas other CYP 
enzymes are less effective. 
 
Discussion 
3-ABA, the human metabolite of the ubiquitous environmental pollutant 3-NBA, was detected 
in the urine of smoking and nonsmoking salt mining workers occupationally exposed to diesel 
emissions at similar concentration (1-143 ng/24 h urine) to 1-aminopyrene (2-200 ng/24 h 
urine), the corresponding amine of the most abundant nitro-polycyclic aromatic hydrocarbons 
detected in diesel exhaust matter (Seidel et al., 2002). The present study has increased our 
knowledge on the potential of CYP enzymes to oxidize this toxicant and on the kinetics of 
such an oxidation.  
The rat was used as an experimental model on the basis that the same enzymes activate 3-
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ABA in human and rat livers to species forming DNA adducts (Arlt et al., 2004b, 2006a; 
Stiborová et al., 2006). Therefore, the results should provide some indication of what might 
occur with 3-ABA in livers of humans. Rat and human hepatic CYP1A1 and/or 1A2 were 
found to be responsible for metabolic activation of 3-ABA (Arlt et al., 2004b). This finding 
corresponds to results found in the present study. Here, we have found that CYP1A enzymes 
are effective in oxidation of 3-ABA to the final oxidative metabolite of this compound, 3-
NBA. Namely, to the metabolite that is formed through the formation of N-hydroxy-3-ABA. 
This reactive intermediate is, however, also decomposed to the ultimate carcinogenic species 
of 3-ABA, nitrenium and/or carbenium ions, forming 3-ABA-derived DNA adducts. Hence, 
this metabolic activation pathway seems to be the prevalent pathway of CYP1A enzymes.   
On the contrary, the CYP enzymes of the 2B subfamily (PB-microsomes), which were the 
most effective in oxidation of 3-ABA, did not form 3-NBA. Likewise, such a pathway was 
also not found for CYPs expressed in livers of untreated rats. Therefore, these CYP enzymes 
seem to play a detoxication role in 3-ABA metabolism. Nevertheless, this finding needs to be 
confirmed by additional studies. For example, the structural characterization of the 3-ABA 
metabolite M18 might shed some light on this feature.  
In conclusion, the study showing for the first time identification of two metabolites 
formed from 3-ABA by CYP-mediated oxidation, confirmed the participation of CYP1A 
enzymes in activation of 3-ABA, namely, in formation of such a metabolite of 3-ABA, which 
is responsible for generation of 3-ABA-derived DNA adducts (N-hydroxy-3-ABA). Other 
CYPs expressed in rat livers are more important for detoxication of this compound. Structural 
characterization of the detoxication metabolite of 3-ABA awaits further investigation. 
 
 
 
 9
References 
Arlt VM (2005) 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and 
urban air pollution: A review of the evidence. Mutagenesis 20: 399–410. 
Arlt VM, Bieler CA, Mier W, Wiessler M and Schmeiser HH (2001) DNA adduct formation 
by the ubiquitous environmental contaminant 3-nitrobenzanthrone in rats determined by 
32P-postlabeling. Int J Cancer 93: 450-454. 
Arlt VM, Cole KJ and Phillips DH (2004a) Activation of 3-nitrobenzanthrone and its 
metabolites to DNA-damaging species in human B-lymphoblastoid MCL-5 cells. 
Mutagenesis 19: 149-156. 
Arlt VM, Glatt HR, Muckel E, Pabel U, Sorg BL, Schmeiser HH and Phillips DH (2002) 
Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human 
acetyltransferases and sulfotransferase. Carcinogenesis 23: 1937–1945. 
Arlt VM, Glatt H, Muckel E, Pabel U, Sorg BL, Seidel A, Frank H, Schmeiser HH and 
Phillips DH (2003a) Activation of 3-nitrobenzanthrone and its metabolites by human 
acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster 
V79 cells. Int J Cancer 105: 583–592. 
Arlt VM, Henderson CJ, Wolf CR, Schmeiser HH, Phillips DH and Stiborová M (2006a) 
Bioactivation of 3-aminobenzanthrone, a human metabolite of the environmental pollutant 
3-nitrobenzanthrone: evidence for DNA adduct formation mediated by cytochrome P450 
enzymes and peroxidases. Cancer Lett 234: 220-231. 
Arlt VM, Hewer A, Sorg BL, Schmeiser HH, Phillips DH and Stiborová M (2004b) 3-
Aminobenzanthrone, a human metabolite of the environmental pollutant 3-
nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver 
microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2. Chem Res 
Toxicol 17: 1092-1101. 
Arlt VM, Schmeiser HH, Osborne MR, Kawanishi M, Kanno T, Yagi T, Phillips DH and 
Takamura-Enya T (2006b) Identification of three major DNA adducts formed by the 
carcinogenic air pollutant 3-nitrobenzanthrone in rat lung at the C8 and N2 position of 
guanine and at the N6 position of adenine. Int J Cancer 118: 2139-2146. 
Arlt VM, Sorg BL, Osborne M, Hewer A, Seidel A, Schmeiser HH and Phillips DH (2003b) 
DNA adduct formation by the ubiquitous environmental pollutant 3-nitrobenzanthrone 
and its metabolites in rats. Biochem Biophys Res Commun 300: 107-114. 
Arlt VM, Stiborová M, Henderson CJ, Osborne MR, Bieler CA, Frei E, Martínek V, Sopko B, 
Wolf CR, Schmeiser HH and Phillips DH (2005) The environmental pollutant and potent 
mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone 
oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human 
hepatic cytosols. Cancer Res 65: 2644-2652. 
Arlt VM, Stiborová M, Hewer A, Schmeiser HH and Phillips DH, (2003c) Human enzymes 
involved in the metabolic activation of the environmental contaminant 3-
nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome P450 
reductase. Cancer Res 63: 2752-2761. 
Arlt, VM, Zhan L, Schmeiser HH, Honma M, Hayashi M, Phillips DH and Suzuki T (2004c) 
DNA adducts and mutagenic specificity of the ubiquitous environmental pollutant 3-
nitrobenzanthrone in Muta Mouse. Environ Mol Mutagen 43: 186-195. 
Bieler CA, Cornelius M, Klein R, Arlt VM, Wiessler M, Phillips DH and Schmeiser HH 
(2005) DNA adduct formation by the environmental contaminant 3-nitrobenzanthrone 
after intratracheal instillation in rats. Int J Cancer 118: 833-838. 
Bieler CA, Cornelius MG, Stiborova M, Arlt VM, Wiessler M, Phillips DH and Schmeiser 
HH (2007) Formation and persistence of DNA adducts formed by the carcinogenic air 
 10
pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation 
in rats. Carcinogenesis 28: 1117-1121. 
Bieler CA, Wiessler M, Erdinger L, Suzuki H, Enya T and Schmeiser HH (1999) DNA adduct 
formation from the mutagenic air pollutant 3-nitrobenzanthrone. Mutat Res 439: 307-
311. 
Borlak J, Hansen T, Yuan Z, Sikka HC, Kumar S, Schmidbauer S, Frank H, Jacob J and 
Seidel A (2000) Metabolism and DNA-binding of 3-nitrobenzanthrone in primary rat 
alveolar type II cells, in human fetal bronchial, rat epithelial and mesenchymal cell lines. 
Polycyclic Aromat Compounds 21: 73-86. 
Enya T, Suzuki H, Watanabe T, Hirayama T and Hisamatsu Y (1997) 3-Nitrobenzanthrone, a 
powerful bacterial mutagen and suspected human carcinogen found in diesel exhausts and 
airborne particulates. Environ Sci Technol 31: 2772-2776. 
Grabchev I, Moneva I, Betcheva R and Elyashevich G (2002) Colored microporous 
polyethylene films: effect of porous structure on dye adsorption. Mat Res Innovat 6: 34-
37. 
Hansen T, Seidel A and Borlak J (2007) The environmental carcinogen 3-nitrobenzanthrone 
and its main metabolite 3-aminobenzanthrone enhance formation of reactive oxygen 
intermediates in human A549 lung epithelial cells. Toxicol Appl Pharmacol 221: 222-234. 
Nagy E, Zeisig M, Kawamura K, Hisumatsu Y, Sugeta A, Adachi S and Moller L (2005) 
DNA-adduct and tumor formations in rats after intratracheal administration of the urban 
air pollutant 3-nitrobenzanthrone. Carcinogenesis 26: 1821-1828. 
Rendic S and DiCarlo FJ (1997) Human cytochrome P450 enzymes: A status report 
summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29: 413-
480. 
Seidel A, Dahmann D, Krekeler H and Jacob J (2002) Biomonitoring of polycyclic aromatic 
compounds in the urine of mining workers occupationally exposed to diesel exhaust. Int J 
Hyg Environ Health 204: 333-338. 
Stiborová M, Dračínská H, Hájková J, Kadeřábková P, Frei E, Schmeiser HH, Souček P, 
Phillips DH and Arlt VM (2006) The environmental pollutant and carcinogen 3-
nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of 
rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase. Drug 
Metab Dispos 34: 1398-1405. 
Stiborová M, Dračínská H, Mizerovská J, Frei E, Schmeiser HH, Hudeček J, Hodek P, 
Phillips DH and Arlt VM 2008 The environmental pollutant and carcinogen 3-
nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase 
in rat lung and kidney, thereby enhancing its own genotoxicity. Toxicology 247: 11-22. 
Stiborová M, Martínek V, Rýdlová H, Hodek P and Frei E (2002) Sudan I is a potential 
carcinogen for humans: evidence for its metabolic activation and detoxication by human 
recombinant cytochrome P450 1A1 and liver microsomes. Cancer Res 62: 5678-5684. 
Svobodová M, Šístková J, Dračínská H, Hudeček J, Hodek P, Schmeiser HH, Arlt VM, Frei E 
and Stiborová M (2007) Reductive activation of environmental pollutants 3-
nitrobenzanthrone and 2-nitrobenzanthrone. Chem Listy 100: s277-s279.  
Sykora J, Mudago V, Hutterer R, Nepras M, Vanerka J, Kapusta P, Fidler V and Hof M 
(2002) ABA-C-15: A new dye for probing solvent relaxation in phospholipid bilayers. 
Langmuir 18: 9276-9282. 
 
 
 
 11
Table 1. The values of IC50 for inhibition of 3-ABA oxidation by CYPs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hepatic microsomes 
from rats pretreated 
with 
Inhibitor IC50 [µM] 
β-naphtoflavone 
(CYP1A1/2) 
α-naphtoflavone 
(CYP1A1/2) 10.9 
β-naphtoflavone 
(CYP1A1/2) 
Furafylline 
(CYP1A2) 16.6 
Control DDTC 
(CYP2E1) 96.8 
Control Sulfaphenazole 
(CYP2C) 10.8 
Phenobarbital 
(CYP2B) 
Diamantane 
(CYP2B) 0.9 
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Legend to figures 
Figure 1. Pathways of metabolic activation and DNA adduct formation of 3-
aminobenzanthrone and 3-nitrobenzanthrone. See the text for details. R = -COCH3 or -SO3H; 
dA-N6-ABA, 2-(2’-deoxyadenosin-N6-yl)-3-aminobenzanthrone; dG-N2-ABA, N-(2’-
deoxyguanosin-N2-yl)-3-aminobenzanthrone; dG-C8-N-ABA, N-(2’-deoxyguanosin-8-yl)-3-
aminobenzanthrone. 
 
Figure 2. HPLC of 3-ABA metabolites produced by hepatic microsomes of rats treated with 
β-NF (A), HPLC of 3-ABA (B), N-hydroxy-3-ABA (C) and 3-NBA (D).  
 
Figure 3. Time dependence of 3-ABA oxidation by hepatic microsomes of rats treated with β-
NF (A), PB (B), and untreated (control microsomes) (C)  
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Fig. 3A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3C 
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